Viewing Study NCT00493337



Ignite Creation Date: 2024-05-05 @ 6:32 PM
Last Modification Date: 2024-10-26 @ 9:34 AM
Study NCT ID: NCT00493337
Status: COMPLETED
Last Update Posted: 2010-06-28
First Post: 2007-06-27

Brief Title: A Community Pharmacist-led Intervention to Improve Adherence to Lipid-lowering Treatment
Sponsor: Utrecht Institute for Pharmaceutical Sciences
Organization: Utrecht Institute for Pharmaceutical Sciences

Study Overview

Official Title: A Community Pharmacist-led Intervention to Improve Adherence to Lipid-lowering Treatment
Status: COMPLETED
Status Verified Date: 2007-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The objective of the study is to test the effectiveness of a community pharmacist-led intervention to increase adherence to lipid lowering treatment
Detailed Description: Medication non-adherence represents an important threat to the health of the Western people A large number of pharmacy records based studies demonstrated that adherence to lipid lowering treatment in daily practice is substantially worse compared to adherence observed in the controlled setting of randomized controlled trials In addition the relationship between non-adherence with statin-treatment assessed with pharmacy records and cardiovascular outcomes has been convincingly demonstrated This implies that pharmacy records can and should be used to identify non-adherent patients and thus patients at risk for major cardiovascular events Using this data community pharmacists can play a more substantive role in developing the concept of pharmaceutical care The objective of the study is to test the effectiveness of a community pharmacist-led intervention to increase adherence to lipid lowering treatment

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None